SCHEMBL7229733

SCHEMBL7229733

CSCCC(NC(C)C(=O)O)C(=O)O

nearest known ligand 0.47

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
RNPEP Q9H4A4 1/20 0.47
ALDH1A1 P00352 3/20 0.47
KDM4E B2RXH2 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
LMNA P02545 2/20 0.46
FOLH1 Q04609 1/20 0.45
NPSR1 Q6W5P4 1/20 0.43
GAA P10253 2/20 0.42
PKM P14618 1/20 0.42
CA2 P00918 2/20 0.41
MAPK1 P28482 1/20 0.41
CA1 P00915 1/20 0.41
FNTA P49354 1/20 0.41
FNTB P49356 1/20 0.41
PGGT1B P53609 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8254544 1.00 RNPEP (0.47) RNPEPALDH1A1KDM4EL3MBTL1LMNA
SCHEMBL30642009 1.00 RNPEP (0.47) RNPEPALDH1A1KDM4EL3MBTL1LMNA
SCHEMBL29561871 1.00 RNPEP (0.47) RNPEPALDH1A1KDM4EL3MBTL1LMNA
SCHEMBL8928051 0.88 RNPEP (0.54) RNPEPALDH1A1KDM4EL3MBTL1LMNA
SCHEMBL15592739 0.86 LMNA (0.51) RNPEPALDH1A1KDM4EL3MBTL1LMNA
SCHEMBL9911535 0.86 LMNA (0.51) RNPEPALDH1A1KDM4EL3MBTL1LMNA
SCHEMBL9194550 0.83 RNPEP (0.55) RNPEPALDH1A1KDM4EL3MBTL1LMNA
SCHEMBL5869722 0.81 FOLH1 (0.58) RNPEPALDH1A1KDM4EL3MBTL1LMNA
SCHEMBL8248682 0.81 FOLH1 (0.58) RNPEPALDH1A1KDM4EL3MBTL1LMNA
SCHEMBL8255575 0.81 RNPEP (0.47) RNPEPALDH1A1KDM4EL3MBTL1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6632830-B1 Blood pressure related disease or disorder, cell proliferation disorder, kidney disorder, kinetensin associated disorder, inflammation associated disorder, or an allergic disorder MILLENNIUM PHARMACEUTICALS, INC. 2003-10-14 US disclosed